Joint (JYNT) Projected to Post Earnings on Thursday

Joint (NASDAQ:JYNT) is expected to be announcing its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect Joint to post earnings of $0.05 per share for the quarter. Interested persons may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, March 12, 2026 at 5:00 PM ET.

Joint Trading Up 3.1%

JYNT stock opened at $8.90 on Thursday. The stock’s 50 day simple moving average is $9.30 and its 200 day simple moving average is $9.18. Joint has a 12-month low of $7.50 and a 12-month high of $13.47. The stock has a market capitalization of $132.34 million, a PE ratio of -148.31 and a beta of 1.33.

Insider Activity at Joint

In other news, major shareholder Charles E. Jobson acquired 16,753 shares of the firm’s stock in a transaction dated Friday, January 23rd. The shares were purchased at an average cost of $10.00 per share, for a total transaction of $167,530.00. Following the transaction, the insider directly owned 1,638,424 shares of the company’s stock, valued at approximately $16,384,240. This trade represents a 1.03% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders bought a total of 47,849 shares of company stock valued at $433,081 over the last 90 days. 27.90% of the stock is owned by company insiders.

Hedge Funds Weigh In On Joint

Several institutional investors have recently bought and sold shares of JYNT. JCP Investment Management LLC bought a new position in shares of Joint during the 2nd quarter worth $5,526,000. Russell Investments Group Ltd. raised its holdings in shares of Joint by 77.3% in the fourth quarter. Russell Investments Group Ltd. now owns 205,411 shares of the company’s stock valued at $1,791,000 after acquiring an additional 89,526 shares in the last quarter. First Foundation Advisors lifted its stake in Joint by 47.8% in the third quarter. First Foundation Advisors now owns 273,759 shares of the company’s stock worth $2,612,000 after acquiring an additional 88,486 shares during the period. Squarepoint Ops LLC bought a new position in Joint during the 4th quarter worth about $766,000. Finally, Topline Capital Management LLC grew its holdings in Joint by 18.7% during the 2nd quarter. Topline Capital Management LLC now owns 449,204 shares of the company’s stock worth $5,184,000 after acquiring an additional 70,910 shares in the last quarter. Institutional investors own 76.88% of the company’s stock.

Analysts Set New Price Targets

JYNT has been the subject of a number of research analyst reports. B. Riley Financial lowered shares of Joint from a “buy” rating to a “hold” rating in a research note on Friday, November 7th. Weiss Ratings restated a “sell (e+)” rating on shares of Joint in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $17.00.

About Joint

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.